LOS oligosaccharide modification enhances dendritic cell responses to meningococcal native outer membrane vesicles expressing a non-toxic lipid A
Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study
Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers
Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults
Ervaringen met bijwerkingen van de eenmalige Meningokokken C vaccinatie-campagne in 2002. Meldingen bij gestimuleerde passieve veiligheidsbewaking
Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: Systemically induced local immunity and saliva as potential surveillance tool
Climate, demographic factors and geographical variations in the incidence of invasive meningococcal disease in Italy
Immunogenicity and safety of monovalent RIVM meningococcal B OMP vesicle F91 vaccine administered to children that received hexavalent meningococcal B vaccine 2.5 years ago
Rijksinstituut voor Volksgezondheid
Rijksinstituut voor Volksgezondheid